Abstract:Pigs are an important resource in agriculture and serve as a model for human diseases. Due to their physiological and anatomical similarities with humans, pigs can recapitulate symptoms of human diseases, making them a useful model in biomedicine. However, in the past pig models have not been widely used partially because of the difficulty in genetic modification. The lack of true embryonic stem cells in pigs forced researchers to utilize genetic modification in somatic cells and somatic cell nuclear transfer (SCNT) to generate genetically engineered (GE) pigs carrying site-specific modifications. Although possible, this approach is extremely inefficient and GE pigs born through this method often presented developmental defects associated with the cloning process. Advancement in the gene-editing systems such as Zinc-Finger Nucleases (ZFNs), Transcription activator-like effector nucleases (TALENs), and the Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) system have dramatically increased the efficiency of producing GE pigs. These gene-editing systems, specifically engineered endonucleases, are based on inducing double-stranded breaks (DSBs) at a specific location, and then site-specific modifications can be introduced through one of the two DNA repair pathways: non-homologous end joining (NHEJ) or homology direct repair (HDR). Random insertions or deletions (indels) can be introduced through NHEJ and specific nucleotide sequences can be introduced through HDR, if donor DNA is provided. Use of these engineered endonucleases provides a higher success in genetic modifications, multiallelic modification of the genome, and an opportunity to introduce site-specific modifications during embryogenesis, thus bypassing the need of SCNT in GE pig production. This review will provide a historical prospective of GE pig production and examples of how the gene-editing system, led by engineered endonucleases, have improved GE pig production. We will also present some of our current progress related to the optimal use of CRISPR/Cas9 system during embryogenesis.

CRISPR Technology Acts as a Dual-Purpose Tool in Pig Breeding: Enhancing Both Agricultural Productivity and Biomedical Applications

Application of genome-editing systems to enhance available pig resources for agriculture and biomedicine.

Global advances in genomic editing in pig breeding

CRISPR/Cas9-Mediated Gene Editing in Porcine Models for Medical Research

Use of gene-editing technology to introduce targeted modifications in pigs

The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research

Improvements in pig agriculture through gene editing

Improvements in Gene Editing Technology Boost Its Applications in Livestock

[Application of single base editing technique in pig genetic improvement: a review]

Genome editing technologies drive the development of pig genetic improvement.

The application of new breeding technology based on gene editing in pig industry - A review

[Progress and application of genome-edited pigs in biomedical research]

Advances in Genetic Engineering of Domestic Animals

Genome‐editing technologies to improve research, reproduction, and production in pigs

Opportunities for CRISPR-Cas9 application in farm animal genetic improvement

Application of new biotechnologies for improvements in swine nutrition and pork production

Cytosine Base Editor (hA3A-BE3-NG)-Mediated Multiple Gene Editing for Pyramid Breeding in Pigs

Enhancing Animal Disease Resistance, Production Efficiency, and Welfare through Precise Genome Editing

Meganucleases Revolutionize the Production of Genetically Engineered Pigs for the Study of Human Diseases

How genome editing changed the world of large animal research

Improve meat production and virus resistance by simultaneously editing multiple genes in livestock using Cas12iMax